Celyad Oncology doses first patient in KEYNOTE-B79 Phase 1b trial
December 16 2021 - 3:51AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Apr 2023 to Apr 2024